INS and diabetes mellitus: Compared with self-monitored blood glucose (SMBG) therapy, these CGM systems were also associated with improvements in hypoglycemia confidence,4,5 diabetes distress,5 and glycemic variability.4 Accordingly, personal real-time CGM systems are now the standard of care for many individuals with insulin-treated diabetes, and the emerging standard of care for countries outside the United States.6